Study Stopped
Recruitment difficulties
Lifestyle Medicine Strategies for Combating Sleepiness and Fatigue in Professional Drivers
HighWay2Health
The Effect of Lifestyle Modifications on Aspects Related to Fatigue, Quality of Life, Health, and Sleepiness in Professional Drivers
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Sleep has a number of health benefits, including memory and learning, vitality and energy as well as high quality of life levels. Lack of sleep impairs judgment, impacts longevity and safety, and increases the risk of a number of diseases including obesity, hypertension, heart disease, diabetes, mood disorders, and impaired immune function. In addition lack of sleep or disturbance of normal sleep cycle could have a major impact on people's lives and working performance such as driving. Daily sleepiness is a problem concerning professions with a non-fixed schedule. Specifically, professional long-haul drivers confront sleepiness problems and in combination with fatigue, they are prone to driving accidents and other incidents. Sleep quality and quantity are closed related to fatigue which is one of the most common reasons for driving and working accidents. In recent years, car accidents involving professional drives have increased significantly. The main reasons for those accidents were fatigue and sleepiness due to long hours of driving or difficult working conditions according to the recent European report (Driver Fatigue in European Road Transport - etf-europe.org). Lifestyle Medicine addresses health risk factors in primary, secondary, and tertiary prevention of developing disease rather than on acute care and reacting to illness, injury, and disease. Lifestyle Medicine strategies targeting modifiable risk factors, such as diet, sleep, stress, and physical activity. By applying those regimes the investigators could improve physical and mental health levels that can affect the quality of sleep, reducing daily sleepiness and fatigue, in professional drivers operating coaches and trucks. Any intervention that could improve alertness and reduce fatigue and sleepiness in those people, will automatically improve safety, reduce driving accidents and save lives and resources.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 30, 2021
CompletedFirst Posted
Study publicly available on registry
October 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedJune 5, 2023
June 1, 2023
1.3 years
September 30, 2021
June 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in Daily Sleepiness
The levels of daily sleepiness will be assessed by a Multiple Sleep Latency Test (MSLT). This is the gold standard approach for assessing daily sleepiness.
Assessed at 0-month (pre) and at 6-month (post)
Changes in Levels fo Fatigue
The levels of fatigue will be assessed by the FSS test
Assessed at 0-month (pre) and at 6-month (post)
Changes in Quality of Sleep
Quality of sleep will be assessed by a full night polysomnography study
Assessed at 0-month (pre) and at 6-month (post)
Secondary Outcomes (4)
Changes in Body composition
Assessed at 0-month (pre) and at 6-month (post)
Changes in Exercise Capacity
Assessed at 0-month (pre) and at 6-month (post)
Changes in Stress levels Work Stress Questionnaire
Assessed at 0-month (pre) and at 6-month (post)
Changes in Quality of Life levels
Assessed at 0-month (pre) and at 6-month (post)
Study Arms (2)
Control Group - No intervention
NO INTERVENTIONThe control group will not participate in any intervention for the duration of the study. In addition, the participants will be instructed to follow their usual daily schedule for 6 months. Changes in health, medication, or habits will be discussed by the investigators' team and reassess the continuation or the termination of the investigated participant.
Lifestyle Medicine Strategies Groupo
EXPERIMENTALThe LSM (LifeStyle Medicine) group, will receive a 6-month lifestyle change intervention targeting the correction of diet, improving physical activity and exercise levels, reducing stress levels, and improving sleep hygiene by LSM registered professionals.
Interventions
LM addresses health risk factors in primary, secondary, and tertiary prevention of developing disease rather than limiting resources and medical expenditures on acute care and reacting to illness, injury, and disease. The intervention will target the four pillars of the LM approach including physical activity, diet, stress, and sleep. Certified in LM strategies professionals will consult participants from the LM group in a biweekly base in order to improve their lifestyle habits.
Eligibility Criteria
You may qualify if:
- both sexes,
- age between 25 and 60 yrs old
- valid 5th category driving license for large trucks and coaches
- minimum of 3 years of continuous and verifiable documented work experience as a professional driver in the past 5 years
- diagnosed with moderate daily sleepiness as this is documented by a value \>9 in Epworth Sleepiness Scale (SSC)
You may not qualify if:
- drivers with a driving license that expires within a year of the recruitment date,
- disabilities that prevent them from walking independently or exercising,
- verified mental illnesses,
- alcoholism or drug abuses,
- or conditions that could affect the outcome of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lifestlye Medicine Laboratory, TEFAA, University of Thessaly
Trikala, Thessaly, 42100, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giorgos K Sakkas, PhD
University of Thessaly
- STUDY CHAIR
Efthmios Dardiotis, MD, PhD
University of Thessaly
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Parameters such as questionnaires' scores, polysomnography outcomes, indices of health, and other data will be masked and coded for blind analysis by the main investigator.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass Professor
Study Record Dates
First Submitted
September 30, 2021
First Posted
October 27, 2021
Study Start
September 1, 2021
Primary Completion
January 1, 2023
Study Completion
January 31, 2023
Last Updated
June 5, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share